Cargando…

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

BACKGROUND: Gefitinib, an EGFR-tyrosine kinase inhibitor, significantly improve prognosis in patients with advanced non-small cell lung cancer (NSCLC). The aim of this study was to evaluate the usefulness of MUC1 and vascular endothelial growth factor (VEGF) mRNA expression in peripheral blood as me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian, Hu, Yi-Ming, Du, Yong-Jie, Zhu, Li-Rong, Qian, Hai, Wu, Yan, Shi, Wei-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246503/ https://www.ncbi.nlm.nih.gov/pubmed/25410981 http://dx.doi.org/10.1186/1471-2407-14-848

Ejemplares similares

The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma
por: Ling, Yang, et al.
Publicado: (2013)

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
por: Fontanini, G, et al.
Publicado: (1999)

MUC1-ARF—A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA
por: Chalick, Michael, et al.
Publicado: (2016)

MUC14-Related ncRNA-mRNA Network in Breast Cancer
por: Wang, Shuqian, et al.
Publicado: (2021)

EXPRESSION OF MUC2 GLYCOPROTEIN ANTIBODY AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN BARRETT’S MUCOSA
por: Ražov Radas, Melanija
Publicado: (2019)

Expression of mRNA vascular endothelial growth factor in hypospadias patients
por: Yuri, Prahara, et al.
Publicado: (2021)

Efficacy of chemotherapy plus gefitinib treatment in advanced non-small-cell lung cancer patients following acquired resistance to gefitinib
por: SONG, ZHENGBO, et al.
Publicado: (2013)

AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations
por: Zhao, Ren, et al.
Publicado: (2016)

Modulation of Mucin (MUC2, MUC5AC and MUC5B) mRNA Expression and Protein Production and Secretion in Caco-2/HT29-MTX Co-Cultures Following Exposure to Individual and Combined Aflatoxin M1 and Ochratoxin A
por: Huang, Xin, et al.
Publicado: (2019)

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
por: Liu, Kejun, et al.
Publicado: (2020)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007)

Human Blood Vessel–Derived Endothelial Progenitors for Endothelialization of Small Diameter Vascular Prosthesis
por: Ranjan, Amaresh K., et al.
Publicado: (2009)

Gefitinib in Non Small Cell Lung Cancer
por: Costanzo, Raffaele, et al.
Publicado: (2011)

Thymoquinone-Induced Tristetraprolin Inhibits Tumor Growth and Metastasis through Destabilization of MUC4 mRNA
por: Lee, Se-Ra, et al.
Publicado: (2019)

Investigation of blood mRNA biomarkers for suicidality in an independent sample
por: Mullins, N, et al.
Publicado: (2014)

Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer
por: Kosaka, Yoshimasa, et al.
Publicado: (2012)

Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers
por: Fujimoto, J, et al.
Publicado: (1999)

M2 macrophages reduce the effect of gefitinib by activating AKT/mTOR in gefitinib‐resistant cell lines HCC827/GR
por: Xiao, Fengqi, et al.
Publicado: (2020)

Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer
por: Horiike, A, et al.
Publicado: (2011)

In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
por: Sha, Huanhuan, et al.
Publicado: (2020)

Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker
por: Chen, Shi, et al.
Publicado: (2023)

Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy
por: Feng, Ye, et al.
Publicado: (2021)

Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
por: Yokoyama, Seiya, et al.
Publicado: (2016)

Gefitinib versus Docetaxel in Treated Non-small-cell Lung Cancer: A Meta-analysis
por: Wang, Bing, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China
por: Shu, Yamin, et al.
Publicado: (2021)

Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
por: Shen, Hua, et al.
Publicado: (2014)

Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients
por: Li, Yun-Fei, et al.
Publicado: (2022)

Identification of Gefitinib Resistance-Related lncRNA-miRNA-mRNA Regulatory Networks and Corresponding Prognostic Signature in Patients with Lung Adenocarcinoma
por: Wang, Taoli, et al.
Publicado: (2022)

Calreticulin regulates vascular endothelial growth factor-A mRNA stability in gastric cancer cells
por: Lee, Po-Chu, et al.
Publicado: (2019)

Alkalescent soda beverage caused the disappearance of gefitinib-induced rashes and decreased efficacy in a non-small-cell lung cancer patient treated with gefitinib: A case report
por: Bian, Shuang, et al.
Publicado: (2020)

Influence of Autophagy Inhibition on Lung Adenocarcinoma Cell Migration and Invasion Ability, and Efficacy of Gefitinib
por: Liu, Ying, et al.
Publicado: (2021)

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
por: Cappuzzo, F, et al.
Publicado: (2004)

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
por: Kim, Youjin, et al.
Publicado: (2019)

Driving vascular endothelial cell fate of human multipotent Isl1(+) heart progenitors with VEGF modified mRNA
por: Lui, Kathy O, et al.
Publicado: (2013)

FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC
por: Zhang, Dan, et al.
Publicado: (2019)

Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization
por: Wang, Shao-bin, et al.
Publicado: (2023)

Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis
por: Yi, Min, et al.
Publicado: (2023)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Biomarkers for Monitoring Pre-Analytical Quality Variation of mRNA in Blood Samples
por: Zhang, Hui, et al.
Publicado: (2014)

Delayed processing of blood samples impairs the accuracy of mRNA-based biomarkers
por: Wilson, Chace, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tn4reptrkavckbn43r2r9lrjfb